Each month, GMO Answers compiles a few stories we think particularly noteworthy. With February being the month of love and romance, at least according to the floral, greeting card, and boxed candy industries, we thought we’d confess our love of science and technology. While the true story of St. Valentine might be somewhat shrouded in mystery, there’s no hiding the fact that we heart evidence-based science. With our love of all things scientific in mind, here are some of the stories that we crushed on in February:
- Can We Trust Science? An article in the Science and Society section of NPR asks if the public can still trust science, and what the scientific community can do to regain whatever trust that may have been lost.
- Where Did the FDA Come From, And What Does It Do? The Smithsonian magazine website explores the Food and Drug Administration (FDA), from its unglamorous origins more than a century ago to how the federal agency works to ensure the safety of everything from lasers to GMOs.
- The Patents Behind the Roses You Receive on Valentine’s Day. D. Lawrence Tarazano, from the U.S. Patent and Trademark Office, writes a very timely guest post, also at Smithsonian.com, about how roses, along with other flowers, plants, fruits, vegetables, trees, and crops, can all be patented.
- GMOs Are Green? Yes, Says Expert. The St. Albert Gazette (Alberta, Canada) profiles renowned plant researcher and geneticist Pamela Ronald, as part of a panel discussion highlighting how GMOs can have a positive impact on the environment.
To read more about these stories, please visit the GMO Answers website, and while you’re there, feel free to explore the rest of the site. It may not be as tasty as box of chocolates, but you never know what you might learn. And you won’t have to worry about all those calories!
Filed under: Farmer Gene, Food And Agriculture, agriculture, Animal biotechnology, Benefits of biotech crops, biotech industry, Dr. Pamela Ronald, FDA, Food, Food and Drug Administration, GMO Answers, Intellectual Property, NPR, patent, Plant biotechnology, Roses, Sustainability, Texas A&M University, thalidomide, US Food and Drug Administration, USPTO